Analyst Coverage

Oryzon Genomics, S.A. is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Oryzon Genomics, S.A.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oryzon Genomics, S.A. or its management. Oryzon Genomics, S.A. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 

Firm Analyst Report
Edison Group (UK)

(in English only)

Jonas Peciulis

2018.07 - Oryzon Genomics - Awaiting for eventful 2019

► Click to see previous Reports

2018.05 - Oryzon Genomics - Phase IIa trial in Alzheimer’s disease initiated

2018.03 - Oryzon Genomics - Multiple data readouts in 2019 within cash reach

2017.12 - Oryzon Genomics - New data support holistic effects of ORY-2001

2017.08 - Oryzon Genomics - ORY-1001 rights back to Oryzon (Update Following Q2-2017 Results)

2017.05 - Oryzon Genomics - ORY-2001 and ORY-3001 next in focus (Update Following Q1-2017 Results)

2017.05 - Oryzon Genomics - Maturing epigenetics portfolio

2017.03 - Oryzon Genomics - New data further back MS indication (Update Following Q4-2016 Results)

2016.12 - Oryzon Genomics - Expanding clinical R&D pipeline

2016.11 - First look at ORY-1001 Phase I/IIa data

2016.11 - Fresh preclinical ORY-2001 data, ORY-1001 next (Update Following Q3-2016 Results)

2016.08 - Oryzon Genomics - Preliminary Phase I/IIa data read-out likely at ASH

2016.05 - Oryzon Genomics continues its march towards success

2016.03 - Oryzon Genomics - Initiation of coverage

▲ Click to hide previous Reports

Invest Securities (FR)

(in English and French only)

Martial Descoutures
Thibaut Voglimacci - Stephanopoli

2018.09 - Oryzon Genomics - Initiation of Coverage. A NEW WAVE (English)   (French)

Luis Navia

(in Spanish only)

Luis Navia

2018.09 - Oryzon Genomics - Resultados del 1S-2018 (Spanish)

► Click to see previous Reports

ROTH Capital Partners (US)

(in English only)

Jotin Marango

2018.09 - Oryzon Genomics - Epigenetic Pipeline Advancing On Multiple Fronts

► Click to see previous Reports

Solventis (ES)

(in Spanish only)

Marta Traver
Manuel González

2018.05 - Research - Oryzon resultados Primer Trimestre 2018 (Spanish)

► Click to see previous Reports